BIOMERICA INC APIC, Share-based Payment Arrangement, Increase for Cost Recognition
BIOMERICA INC (BMRA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $118.00 thousand for the 3-month period ending 2025-11-30, per its 10-Q filed 2026-04-13.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-04-13
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-11-30 was $118.00K, a 23.87% decline year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-02-28 was $120.00K, a 64.81% decline year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-11-30 was $155.00K, a 27.05% increase year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-08-31 was $77.00K, a 54.71% decline year-over-year.
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $460.00K, a 45.04% decline from fiscal 2024.
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $837.00K, a 29.37% decline from fiscal 2023.
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.19M, a 5.95% decline from fiscal 2022.
- BIOMERICA INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.26M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-11-30 | $118.00K 10-Q · filed 2026-04-13 | |||
| 2025-05-31 | $460.00K 10-K · filed 2025-08-29 | |||
| 2025-02-28 | $120.00K 10-Q · filed 2025-04-14 | $275.00K derived: sum of 2 quarters · filed 2026-01-14 | $352.00K derived: sum of 3 quarters · filed 2026-01-14 | |
| 2024-11-30 | $155.00K 10-Q · filed 2026-01-14 | $232.00K derived: sum of 2 quarters · filed 2026-01-14 | ||
| 2024-08-31 | $77.00K 10-Q · filed 2026-01-14 | |||
| 2024-05-31 | $837.00K 10-K · filed 2025-08-29 | |||
| 2024-02-29 | $341.00K 10-Q · filed 2025-04-14 | $463.00K derived: sum of 2 quarters · filed 2025-04-14 | $633.00K derived: sum of 3 quarters · filed 2025-04-14 | |
| 2023-11-30 | $122.00K 10-Q · filed 2025-04-14 | $292.00K derived: sum of 2 quarters · filed 2025-04-14 | ||
| 2023-08-31 | $170.00K 10-Q · filed 2025-04-14 | |||
| 2023-05-31 | $1.19M 10-K · filed 2023-08-25 | |||
| 2023-02-28 | $384.00K 10-Q · filed 2024-04-12 | $702.00K derived: sum of 2 quarters · filed 2024-04-12 | $1.01M derived: sum of 3 quarters · filed 2024-04-12 | |
| 2022-11-30 | $318.00K 10-Q · filed 2024-04-12 | $622.00K derived: sum of 2 quarters · filed 2024-04-12 | ||
| 2022-08-31 | $304.00K 10-Q · filed 2024-04-12 | |||
| 2022-05-31 | $1.26M 10-K · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |